IHC was carried out in 75 specimens to examine the expression of p53, Beclin-1 and PCDH17 in UBC patients who underwent surgical treatment (cystectomy, transurethral resection of bladder tumor), which was selected regarding to the AJCC guideline (Table 1). The gene discussed is BECN1; the disease is urinary bladder neoplasm.